NXTC earnings: a positive outcome, +19.1%

On March 21, 2024, NextCure, Inc. reached its earnings. The result was a positive outcome, and the stock moved +19.1% in the window around the event. It had already run -8.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.